Montecito Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Sell
26,984
-3,340
-11% -$87.4K 0.1% 177
2026
Q1
$851K Sell
30,324
-27
-0.1% -$719 0.14% 141
2025
Q4
$756K Sell
30,351
-196
-0.6% -$4.94K 0.12% 158
2025
Q3
$778K Buy
+30,547
New +$754K 0.12% 161
2025
Q1
$961K Sell
37,939
-3,583
-9% -$93.8K 0.17% 136
2024
Q4
$1.1M Sell
41,522
-70
-0.2% -$1.9K 0.19% 124
2024
Q3
$1.2M Buy
41,592
+5,217
+14% +$152K 0.21% 112
2024
Q2
$1.02M Sell
36,375
-4,166
-10% -$115K 0.21% 113
2024
Q1
$1.13M Sell
40,541
-1,179
-3% -$32.7K 0.23% 106
2023
Q4
$1.2M Sell
41,720
-7,842
-16% -$237K 0.26% 98
2023
Q3
$1.64M Sell
49,562
-3,389
-6% -$120K 0.39% 60
2023
Q2
$1.94M Sell
52,951
-3,257
-6% -$127K 0.44% 52
2023
Q1
$2.29M Sell
56,208
-325
-0.6% -$14K 0.55% 45
2022
Q4
$2.9M Sell
56,533
-1,129
-2% -$54.1K 0.7% 35
2022
Q3
$2.52M Sell
57,662
-7,956
-12% -$387K 0.66% 39
2022
Q2
$3.44M Sell
65,618
-5,357
-8% -$273K 0.82% 32
2022
Q1
$3.67M Sell
70,975
-2,263
-3% -$117K 0.69% 39
2021
Q4
$4.33M Sell
73,238
-603
-0.8% -$29.9K 0.77% 32
2021
Q3
$3.18M Buy
73,841
+653
+0.9% +$28.9K 0.62% 42
2021
Q2
$2.87M Buy
73,188
+2,936
+4% +$114K 0.55% 46
2021
Q1
$2.54M Buy
70,252
+2,779
+4% +$98.7K 0.53% 50
2020
Q4
$2.48M Sell
67,473
-2,219
-3% -$81.4K 0.54% 46
2020
Q3
$2.43M Buy
69,692
+7,565
+12% +$265K 0.62% 45
2020
Q2
$1.93M Sell
62,127
-4,245
-6% -$144K 0.53% 48
2020
Q1
$2.06M Sell
66,372
-67
-0.1% -$2.28K 0.67% 36
2019
Q4
$2.47M Buy
66,439
+9,222
+16% +$328K 0.66% 35
2019
Q3
$1.95M Sell
57,217
-50
-0.1% -$1.82K 0.58% 40
2019
Q2
$2.35M Sell
57,267
-1,623
-3% -$64.4K 0.71% 31
2019
Q1
$2.37M Buy
58,890
+300
+0.5% +$12K 0.73% 33
2018
Q4
$2.43M Sell
58,590
-634
-1% -$26.3K 0.84% 27
2018
Q3
$2.48M Buy
59,224
+5,218
+10% +$201K 0.74% 29
2018
Q2
$1.86M Buy
54,006
+1,358
+3% +$46.4K 0.6% 30
2018
Q1
$1.77M Buy
52,648
+3,626
+7% +$125K 0.58% 38
2017
Q4
$1.69M Buy
49,022
+438
+0.9% +$14.9K 0.55% 33
2017
Q3
$1.65M Sell
48,584
-3,425
-7% -$110K 0.57% 29
2017
Q2
$1.66M Sell
52,009
-7,537
-13% -$238K 0.6% 31
2017
Q1
$1.93M Sell
59,546
-1,033
-2% -$32.6K 0.71% 27
2016
Q4
$1.87M Buy
60,579
+2,470
+4% +$75.4K 0.65% 33
2016
Q3
$1.87M Buy
58,109
+3,118
+6% +$104K 0.77% 32
2016
Q2
$1.84M Sell
54,991
-1,749
-3% -$55.8K 0.78% 26
2016
Q1
$1.6M Buy
56,740
+1,379
+2% +$39.4K 0.72% 29
2015
Q4
$1.7M Buy
55,361
+6,177
+13% +$194K 0.8% 24
2015
Q3
$1.47M Sell
49,184
-10,101
-17% -$324K 0.81% 22
2015
Q2
$1.96M Hold
59,285
0.97% 23
2015
Q1
$1.96M Sell
59,285
-322
-0.5% -$10.2K 0.97% 23
2014
Q4
$1.76M Buy
59,607
+1,489
+3% +$42.7K 0.93% 25
2014
Q3
$1.63M Sell
58,118
-3,782
-6% -$106K 0.99% 21
2014
Q2
$1.74M Sell
61,900
-1,338
-2% -$38.1K 1.05% 20
2014
Q1
$1.93M Buy
63,238
+1,395
+2% +$41.6K 1.21% 15
2013
Q4
$1.8M Sell
61,843
-1,126
-2% -$32.8K 1.12% 17
2013
Q3
$1.72M Sell
62,969
-3,884
-6% -$106K 1.14% 18
2013
Q2
$1.78M Buy
+66,853
New +$1.85M 1.2% 17

Other funds holding PFE

Montecito Bank & Trust's PFE Position: Q2 2026 in Review

Montecito Bank & Trust reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $87.4K and leaving 26,984 shares worth $650K. The position accounts for 0.1% of the portfolio, ranked #177.

Montecito Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.33M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Montecito Bank & Trust held 26,984 shares of Pfizer worth $650K as of Q2 2026.
  • Montecito Bank & Trust sold 3,340 Pfizer shares in Q2 2026, an estimated $87.4K.
  • Pfizer made up 0.1% of Montecito Bank & Trust's portfolio in Q2 2026, its #177 holding.
  • Montecito Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Montecito Bank & Trust's Pfizer position peaked at $4.33M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.